Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Global protein-expression profiling for reclassification of malignant fibrous histiocytoma.
[liposarcoma]
According
to
the
newest
World
Health
Organization
(
WHO
)
classification
for
soft
tissue
tumors
in
2013
,
malignant
fibrous
histiocytoma
(
MFH
)
has
been
gone
.
Most
sarcomas
called
MFH
were
reclassified
to
be
high
-grade
pleomorphic
forms
of
leiomyosarcoma
,
liposarcoma
,
rhabdomyosarcoma
,
and
other
sarcomas
by
recent
molecular
technologies
.
However
,
about
10
%
to
15
%
of
sarcomas
called
MFH
before
,
still
can
not
be
given
a
precise
classification
,
and
these
are
now
called
undifferentiated
pleomorphic
sarcoma
or
are
still
called
MFH
.
Further
molecular
approaches
including
proteomic
approaches
are
imperative
to
classify
these
unclassified
sarcomas
for
improving
clinical
outcomes
of
the
patients
with
soft
tissue
sarcomas
.
This
article
is
part
of
a
Special
Issue
entitled
:
Medical
Proteomics
.